Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for TMJ Dislocation
NCT05863286Unknown
- Sponsor
- Cairo University
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in temporomandibular joint dislocation comparing Botulinum toxin type A with Placebo (2 arms). Primary endpoints: Frequency of luxation at 6 months and Maximum Mouth opening at 6 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular joint dislocation
Beyond the preview
Go deeper on NCT05863286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05863286.